Laboratory methods for KRAS mutation analysis (Q37899889)

25 August 2017

1 reference

title

Laboratory methods for KRAS mutation analysis (English)

1 reference

25 August 2017

1 reference

Steven M Anderson

1

1 reference

25 August 2017

1 July 2011

1 reference

Expert Review of Molecular Diagnostics: new diagnostic technologies are set to revolutionise healthcare

25 August 2017

1 reference

25 August 2017

11

1 reference

25 August 2017

6

1 reference

25 August 2017

635-642

1 reference

KRAS mutations in non-small cell lung cancer

25 August 2017

1 reference

KRAS mutations: an old oncogene becomes a new predictive biomarker

21 January 2018

1 reference

Molecular targeted therapies in head and neck cancer--an update of recent developments-

21 January 2018

1 reference

KRAS mutations as an independent prognostic factor in patients with advanced colorectal cancer treated with cetuximab.

21 January 2018

1 reference

K-ras mutations and benefit from cetuximab in advanced colorectal cancer.

21 January 2018

1 reference

Karyotype evolution on fluorescent in situ hybridization analysis is associated with short survival in patients with chronic lymphocytic leukemia and is related to CD49d expression

21 January 2018

1 reference

Bleomycin in testicular cancer: will pharmacogenomics improve treatment regimens?

21 January 2018

1 reference

KRAS wild-type state predicts survival and is associated to early radiological response in metastatic colorectal cancer treated with cetuximab

21 January 2018

1 reference

Clinical relevance of KRAS mutation detection in metastatic colorectal cancer treated by Cetuximab plus chemotherapy

21 January 2018

1 reference

Wild-type KRAS is required for panitumumab efficacy in patients with metastatic colorectal cancer

21 January 2018

1 reference

Wild-type BRAF is required for response to panitumumab or cetuximab in metastatic colorectal cancer

21 January 2018

1 reference

American Society of Clinical Oncology provisional clinical opinion: testing for KRAS gene mutations in patients with metastatic colorectal carcinoma to predict response to anti-epidermal growth factor receptor monoclonal antibody therapy

21 January 2018

1 reference

Molecular characteristics of bronchioloalveolar carcinoma and adenocarcinoma, bronchioloalveolar carcinoma subtype, predict response to erlotinib

21 January 2018

1 reference

KRAS mutation is an important predictor of resistance to therapy with epidermal growth factor receptor tyrosine kinase inhibitors in non-small-cell lung cancer

21 January 2018

1 reference

KRAS mutations and sensitivity to epidermal growth factor receptor inhibitors in colorectal cancer: practical application of patient selection

21 January 2018

1 reference

KRAS mutation testing for predicting response to anti-EGFR therapy for colorectal carcinoma: proposal for an European quality assurance program.

21 January 2018

1 reference

Frequency and type of KRAS mutations in routine diagnostic analysis of metastatic colorectal cancer

21 January 2018

1 reference

EML4-ALK lung cancers are characterized by rare other mutations, a TTF-1 cell lineage, an acinar histology, and young onset.

21 January 2018

1 reference

Optimized allele-specific real-time PCR assays for the detection of common mutations in KRAS and BRAF.

21 January 2018

1 reference

Comparison of Sanger sequencing, pyrosequencing, and melting curve analysis for the detection of KRAS mutations: diagnostic and clinical implications

21 January 2018

1 reference

COLD-PCR enhanced melting curve analysis improves diagnostic accuracy for KRAS mutations in colorectal carcinoma

21 January 2018

1 reference

A commercial real-time PCR kit provides greater sensitivity than direct sequencing to detect KRAS mutations: a morphology-based approach in colorectal carcinoma

21 January 2018

1 reference

A multicenter blinded study to evaluate KRAS mutation testing methodologies in the clinical setting

21 January 2018

1 reference

KRAS genotyping of paraffin-embedded colorectal cancer tissue in routine diagnostics: comparison of methods and impact of histology

21 January 2018

1 reference

A comparability study of 5 commercial KRAS tests

21 January 2018

1 reference

Association of KRAS p.G13D mutation with outcome in patients with chemotherapy-refractory metastatic colorectal cancer treated with cetuximab

21 January 2018

1 reference

Sensitive sequencing method for KRAS mutation detection by Pyrosequencing

21 January 2018

1 reference

Molecular testing for somatic mutations improves the accuracy of thyroid fine-needle aspiration biopsy

21 January 2018

1 reference

Analysis of circulating tumor DNA to confirm somatic KRAS mutations.

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1586/ERM.11.42

1 reference

25 August 2017

1 reference

PubMed ID

21745016